Biotech news
Asia
The Indian government has awarded more than two thirds of its recent pharmaceutical patents to foreign drug makers, according to data released by the Indian Patent Office. 16 September 2013
Asia
The Health Ministry in India has recommended that a compulsory licence is issued for the manufacture of Bristol-Myers Squibb’s anti-cancer drug Sprycel (dasatinib), potentially opening the door to the sale of cheaper imitations. 12 September 2013
Biotech
UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership. 28 August 2013
Pharma
Austria has become the first country in the EU to ratify consent to the Unified Patent Court. 27 August 2013
Americas
Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims. 8 August 2013
Americas
Danish firm Bavarian Nordic has a portfolio of patents for vaccines and cancer treatments, but likes to keep some of its cards close to its chest, as LSIPR finds out. 31 July 2013
Americas
Gabriel Di Blasi outlines the existing impediments to developing new biotechnology products in Brazil,
and considers recent efforts to improve the situation. 31 July 2013
Americas
A US court has upheld a decision ruling that a continuation patent filed by a bio-tech company is invalid. 26 July 2013
Americas
Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer. 19 July 2013
Biotech
On July 15, French pharmaceutical company Ipsen announced it has closed the acquisition of life sciences company and research partner Syntaxin. 18 July 2013